Journal Article Summary
The article investigates a concerning cluster of Neisseria gonorrhoeae isolates in Hawaii that show high-level resistance to azithromycin and decreased susceptibility to ceftriaxone. This topic is significant because gonorrhea is a common sexually transmitted infection, and the emergence of antibiotic-resistant strains poses a serious public health threat. The Centers for Disease Control and Prevention (CDC) recommends dual therapy with ceftriaxone and azithromycin to effectively treat gonorrhea and mitigate the development of resistance. The findings highlight the potential for treatment failures if these resistant strains become more widespread.
The study involved eight isolates from seven patients in Oahu, Hawaii, collected between April and May 2016. All isolates demonstrated high-level resistance to azithromycin and varying degrees of decreased susceptibility to ceftriaxone. Laboratory tests confirmed that all isolates were resistant to several other antibiotics, including penicillin, tetracycline, and ciprofloxacin. The patients were treated successfully, but the genetic analysis revealed that the isolates were closely related, indicating a potential outbreak of resistant strains in the community.
Limitations of the study include the small sample size and the fact that all patients were symptomatic, which may not represent the broader population of gonorrhea cases. Patients should be aware of the risks associated with antibiotic-resistant infections and discuss any concerns with their healthcare providers, especially if they experience persistent symptoms after treatment. It is crucial for healthcare professionals to remain vigilant in monitoring for treatment failures and to consider culture-based testing for patients who may not respond to standard therapies. This proactive approach can help manage and contain the spread of resistant strains.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Katz Alan R., Komeya Alan Y., Kirkcaldy Robert D., Whelen A. Christian, Soge Olusegun O., Papp John R., Kersh Ellen N., Wasserman Glenn M., et al.. Cluster of Neisseria gonorrhoeae Isolates With High-level Azithromycin Resistance and Decreased Ceftriaxone Susceptibility, Hawaii, 2016. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017. DOI: 10.1093/cid/cix485. PMID: 28549097. PMCID: PMC6748320.
Featured Pill Pals Product
Azithromycin 250 mg Tablet Six (6) Pack --- TEVA Pharma --- Generic For Z Pack / Zithromax
Azithromycin 250 mg Tablet Six (6) Pack — TEVA Pharma — Generic For Z Pack / Zithromax is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
